A promising target to fight inflammatory bowel diseases
Inflammatory bowel diseases (IBDs), such as Crohn's disease or ulcerative colitis, arise when there is a dysregulation of cell signalling pathways, leading to a chronic inflammatory response. The gut inflammatory response relies on a chain reaction involving several molecules, including RIPK2 --...
www.sciencedaily.com
Interesting research. The question is how soon can we have newer medications and clinical trials?